In this assay, AD-tau was again used to seed aggregation of tau pathology in rat cortical neuron cultures in the absence or presence of compounds as described for the primary screen, except that 96-well plates were used with compounds tested in duplicate. Here, MAPT is linked to Alzheimer disease.